Connect your AI

Evommune EVMN Net additions (releases) charged to costs and expenses

Net additions (releases) charged to costs and expenses at other companies

T-Mobile USTMUS

$426M+31.9%

Mercado LibreMELI

$1.24B+106%

Robinhood Markets, Inc.HOOD

$36M+50.0%

QuidelOrtho CorporationQDEL

$137.53M+13.1%

WEC Energy GroupWEC

-$7.3M-115%

Diversified Energy DEC

$5M—

Other financials

Income statement

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's net additions (releases) charged to costs and expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evommune 's net additions (releases) charged to costs and expenses?: Evommune (EVMN) reported net additions (releases) charged to costs and expenses of -$1.97K in Q1 2025.
How has Evommune 's net additions (releases) charged to costs and expenses changed year-over-year?: Evommune 's net additions (releases) charged to costs and expenses increased by 75.8% year-over-year, from -$8.12K to -$1.97K.